Filing Flows › Cue Biopharma (CUE) › How it makes money
How Cue Biopharma (CUE) makes money
Cue Biopharma (CUE) made $7.9M of revenue in the second quarter 2026 (Q2 2026), +167% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $7.9M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $7.9M | +167% |
| Q1 2026 | $5.7M | 14× |
| Q4 2025 | $21.9M | 14× |
| Q3 2025 | $2.1M | -36% |
| Q2 2025 | $3.0M | +11% |
| Q1 2025 | $421K | -76% |
| Q4 2024 | $1.6M | -14% |
From Cue Biopharma's 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Cue Biopharma make money?
Cue Biopharma (CUE) made $7.9M of revenue in the second quarter 2026 (Q2 2026), +167% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.